Resumption of Ovarian Function and Pregnancies in 358 Patients with Premature Ovarian Failure

被引:154
作者
Bidet, Maud [1 ,2 ]
Bachelot, Anne [1 ,2 ]
Bissauge, Estelle [1 ,2 ]
Golmard, Jean Louis [5 ]
Gricourt, Solenne [1 ,2 ]
Dulon, Jerome [1 ,2 ]
Coussieu, Christiane [4 ]
Badachi, Yasmina [3 ]
Touraine, Philippe [1 ,2 ]
机构
[1] Grp Hosp Pitie Salpetriere, AP HP, Dept Endocrinol & Reprod Med, F-75013 Paris, France
[2] Univ Paris 06, Ctr Reference Malad Endocriniennes Rares Croissan, F-75005 Paris, France
[3] Grp Hosp Pitie Salpetriere, AP HP, Dept Radiol, F-75013 Paris, France
[4] Grp Hosp Pitie Salpetriere, Dept Hormonal Biochem, F-75013 Paris, France
[5] Grp Hosp Pitie Salpetriere, Unite Rech Clin, F-75013 Paris, France
关键词
ANTI-MULLERIAN HORMONE; FOLLICLE-STIMULATING-HORMONE; SERUM ANDROGEN LEVELS; CONTROLLED-TRIAL; HYPERGONADOTROPIC AMENORRHEA; GONADOTROPIN SUPPRESSION; OVULATION INDUCTION; INHIBIN-B; WOMEN; ESTRADIOL;
D O I
10.1210/jc.2011-1038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Resumption of ovarian activity and spontaneous pregnancies are described in patients with premature ovarian failure (POF), but there is a lack of data concerning the prevalence of and predictive factors for these phenomena. Objective: The aim of the study was to determine both the prevalence of and predictive factors for spontaneous resumption of ovarian function in POF patients. Design and Setting: A mixed retrospective and prospective study was performed at a referral center for reproductive endocrinology. Patients: A total of 358 consecutive POF patients were followed from 1997 to 2010 in our center. Main Outcomes Measures: The cumulative incidence of resumption of ovarian function was determined, and predictive factors were identified by univariate and multivariate analysis. Results: Of 358 patients with idiopathic POF, 86 (24%) patients presented features indicating resumption of ovarian function, and in 77 cases (88%) within 1 yr of diagnosis. Twenty-one spontaneous pregnancies (16 births, five miscarriages) occurred in 15 (4.4%) patients. Multivariate analysis (Cox model) showed that a familial history of POF, secondary amenorrhea, presence of follicles at ultrasound, and inhibin B and estradiol levels were significantly predictive of resumption of ovarian function (P < 0.01), whereas association with an autoimmune disease, anti-Mullerian hormone level, the presence of follicles on biopsy, and/or genetic abnormalities did not appear predictive. We created a predictive score for resumption of ovarian function comprising age at diagnosis, presence of follicles at ultrasound, and inhibin B level. Conclusion: Intermittent ovarian activity in patients with POF is not a rare phenomenon. The predictive score described in this study may help us to identify POF patients most likely to recover intermittent ovarian function. (J Clin Endocrinol Metab 96: 3864-3872, 2011)
引用
收藏
页码:3864 / 3872
页数:9
相关论文
共 38 条
[11]   Regulation of ovarian function: the role of anti-Mullerian hormone [J].
Durlinger, ALL ;
Visser, JA ;
Themmen, APN .
REPRODUCTION, 2002, 124 (05) :601-609
[12]   Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity [J].
Falorni, A ;
Laureti, S ;
Candeloro, P ;
Perrino, S ;
Coronella, C ;
Bizzarro, A ;
Bellastella, A ;
Santeusanio, F ;
De Bellis, A .
FERTILITY AND STERILITY, 2002, 78 (02) :270-279
[13]   Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists [J].
Fanchin, R ;
Salomon, L ;
Castelo-Branco, A ;
Olivennes, F ;
Frydman, N ;
Frydman, R .
HUMAN REPRODUCTION, 2003, 18 (12) :2698-2703
[14]   Discordances between follicle stimulating hormone (FSH) and anti-Mullerian hormone (AMH) in female infertility [J].
Gleicher, Norbert ;
Weghofer, Andrea ;
Barad, David H. .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2010, 8
[15]   Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol [J].
Hazout, A ;
Bouchard, P ;
Seifer, DB ;
Aussage, P ;
Junca, AM ;
Cohen-Bacrie, P .
FERTILITY AND STERILITY, 2004, 82 (05) :1323-1329
[16]   Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure [J].
Kim, TJ ;
Anasti, JN ;
Flack, MR ;
Kimzey, LM ;
Defensor, RA ;
Nelson, LM .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (05) :777-779
[17]   SPONTANEOUS AND PHARMACOLOGICALLY INDUCED REMISSIONS IN PATIENTS WITH PREMATURE OVARIAN FAILURE [J].
KREINER, D ;
DROESCH, K ;
NAVOT, D ;
SCOTT, R ;
ROSENWAKS, Z .
OBSTETRICS AND GYNECOLOGY, 1988, 72 (06) :926-928
[18]   Premature ovarian failure and dehydroepiandrosterone [J].
Mamas, Leonidas ;
Mamas, Eudoxia .
FERTILITY AND STERILITY, 2009, 91 (02) :644-646
[19]   Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure [J].
Massin, N. ;
Meduri, G. ;
Bachelot, A. ;
Misrahi, M. ;
Kuttenn, F. ;
Touraine, P. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2008, 282 (1-2) :95-100
[20]   Serum anti-Mullerian hormone expression in women with premature ovarian failure [J].
Meduri, G. ;
Massin, N. ;
Guibourdenche, J. ;
Bachelot, A. ;
Fiori, O. ;
Kuttenn, F. ;
Misrahi, M. ;
Touraine, P. .
HUMAN REPRODUCTION, 2007, 22 (01) :117-123